This program contains embargoed material that will be presented at the ASBMR 31st Annual Meeting in Denver, Colorado, USA, September 11-15, 2009.
ASBMR EMBARGO POLICY
If you are visiting this site on or before the day of presentation for a particular abstract, please note that the abstracts submitted to the ASBMR 31st Annual Meeting are embargoed - that is, unavailable for public release in written, oral and electronic communications - until one hour after they have been presented.
The ASBMR is sensitive to issues of commercial confidentiality and relevant aspects of the U.S. Securities and Exchange Commission (SEC) Regulations. Therefore, all users of the ASBMR 31st Annual Meeting Abstracts Online and Itinerary Builder Website must adhere to the Securities and Exchange Commission regulations and treat all information as confidential until the embargo has been lifted - one hour after the abstract has been presented. Users of this site may be viewed as "insiders" by the SEC due to their knowledge of information included in abstracts, particularly clinical trial abstracts. Acting on information included in these abstracts - prior to their public release after the embargo has been lifted - may subject individuals to criminal penalties.
If you have any questions about the abstract embargo, please contact ASBMR Media Relations Manager Gina Spear at email@example.com or +1 (202) 367-1219 before September 11, 2009. As of September 11, 2009, and through September 15, 2009, she can be reached on-site in the ASBMR Annual Meeting Press Room. If you have any questions about your abstract submission, please contact the ASBMR Business Office at firstname.lastname@example.org or +1 (202) 367-1161.
By clicking on the link below ("I AGREE"), you will acknowledge your understanding of and agreement to uphold the ASBMR Embargo Policy, comply with the SEC Regulations, and to keep the content of all ASBMR abstracts confidential until the embargo has been lifted.
I understand the ASBMR Embargo Policy, which is that ASBMR abstracts are unavailable for public release in written, oral and electronic communications - until one hour after an abstract or abstracts has/have been presented.
Furthermore, I agree that under no circumstances will I share with others the information from abstracts or the abstracts themselves, nor will I make use of any "insider" information gained by previewing ASBMR abstracts. The abstracts are available for public release only after one hour following the time of their presentation.
COPYRIGHT AND REPRINTS
Abstracts submitted to the ASBMR 31st Annual Meeting and published electronically on the ASBMR Website in the Abstracts-On-Line and in the PDF Supplement to the Journal of Bone and Mineral Research are copyrighted by the American Society for Bone and Mineral Research. Reproduction, distribution or transmission of the abstracts in whole or in part, by electronic, mechanical or other means, or intended use, is prohibited without the express written permission of the American Society for Bone and Mineral Research. All inquiries regarding copyrighted material or reprint orders should be directed to Robert Fulcher, Interim Director of Publications, American Society for Bone and Mineral Research, E-mail: email@example.com, Tel: + (919) 620-0681; Fax: +1 (919) 620-8465, Postal Address: PO Box 12861, Durham, NC 27709, USA.
No responsibility is assumed, and responsibility is hereby disclaimed, by the American Society for Bone and Mineral Research for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of methods, products, instructions, or ideas presented in the materials herein. Independent verification of diagnosis and drug dosages should be made. Discussions, views and recommendations as to medical procedures, choice of drugs and drug dosages are the responsibility of the authors.